Read the full report for just $299
This report is a meta-analysis of studies conducted between 1990 and 2018. These studies analyzed the safety of commercially available ashwagandha preparations available to United States consumers over this time period.
The report summarizes the conclusions of these studies for the benefit of regulatory officials and industry stakeholders.
To make a purchase and receive digital access to the report, send an email to reports@supplementdb.org from a business or government email address.